Thiotriazoline solution for intravenous and intramuscular injection 25mg/ml in ampoules 4ml №5×2

Name Thiotriazolin solution for intravenous and intramuscular injection.25 mg/ml in 4ml amp. The main active ingredient is Morpholinium-methyl-triazolyl-thioacetate Form of release: 2 ml in an ampoule, 10 ampoules in a blister pack, 1 blister pack in a pack. 4 ml in an ampoule, 5 ampoules in a blister pack, 2 blister packs in a pack. Dosage 25mg/ml in 4ml amp. The pharmacological effect is due to anti-ischemic, antioxidant, membrane-stabilizing and immunomodulatory properties. It prevents the death of hepatocytes, reduces the degree of their fatty infiltration and the spread of centrilobular necrosis of the liver, promotes the regeneration of hepatocytes, normalizes protein, carbohydrate, lipid and pigment metabolism. Increases the amount of synthesis and excretion of bile, normalizes its chemical composition. Thiotriazolin® enhances the compensatory activation of anaerobic glycolysis, reduces the inhibition of oxidation processes in the Krebs cycle while maintaining the intracellular ATP pool. The drug activates the antioxidant system and inhibits the processes of lipid oxidation in ischemic areas. Improves the rheological properties of blood (activates the fibrinolytic system). Pharmacokinetics Cmax in blood plasma with intramuscular injection is 399 μg / ml, the time to reach Cmax is 0.84 hours with intramuscular injection and 0.1 hour with intravenous administration. Vd – 318.0 ml. The degree of absolute bioavailability is 34.6%. Indications for use – toxic liver damage, incl. alcoholic, viral and medicinal origin (taking antibiotics, antitumor, antituberculosis, antiviral drugs, tricyclic antidepressants, oral contraceptives); – chronic alcoholic hepatitis of minimal and moderate activity; – chronic viral hepatitis; – fatty degeneration of the liver; – cirrhosis of the liver. Dosage and administration For adults with acute myocardial infarction, chronic hepatitis with severe activity of the process Thiotriazoline in the first 5 days is administered intramuscularly at 2 ml of a 25 mg / ml solution (50 mg each) 2-3 times a day or intravenously slowly at a rate of 2 ml / min 4 ml of 25 mg / ml (100 mg) 1 time per day, or drip at a rate of 20–30 drops per minute (2 ampoules of a 25 mg / ml solution are diluted in 150–250 ml of 0.9% sodium chloride solution). From the fifth to the twentieth day of therapy, Thiotriazoline is prescribed in tablets (at a dose of 100 mg 3 times a day). In angina pectoris FC II-III, it is recommended to administer 4 ml of a 25 mg / ml solution 2 times a day (daily dose – 200 mg) intramuscularly for 10 days, then orally in the form of Thiotriazoline tablets (200 mg) 3 times a day for for 20 days. In chronic hepatitis of minimal and moderate activity, Thiotriazoline is administered intramuscularly at 2 ml of a 25 mg / ml solution 2 times a day for 10 days, then continuing to take it orally in the form of tablets (100 mg 3 times a day) up to 20 days. With cirrhosis of the liver, the course of treatment is 60 days. Treatment begins with intramuscular injection of 2 ml of a 25 mg / ml solution (50 mg) 3 times a day for 5 days, and then continue treatment with Thiotriazoline in the form of tablets (at a dose of 100 mg 3 times a day). Use during pregnancy and lactation Use of the drug during pregnancy and lactation is contraindicated. Precautions Contraindicated in renal failure. Contraindicated in childhood. Contraindications – renal failure; – childhood; – pregnancy; – lactation period; – Hypersensitivity to the components of the drug. Composition 1 ml of the solution contains: active ingredient: morpholinium salt of thiazoic acid, which is equivalent to 33.3 mg of thiazoic acid – 50.0 mg (for 2 ml); morpholinium salt of thiazoic acid, which is equivalent to 66.6 mg of thiazoic acid – 100.0 mg (for 4 ml). excipient: water for injection. Overdose Cases of overdose are unknown. Side effectsThiotriazolin® is generally well tolerated. In the clinical use of Thiotriazolin, the following adverse reactions are extremely rare: From the digestive system: nausea, dry mouth, bloating. From the side of the central nervous system: general weakness, dizziness, tinnitus. From the side of the cardiovascular system: tachycardia, increased blood pressure, pain in the heart, arrhythmias. From the respiratory system: very rarely – shortness of breath, asthma attacks. Allergic reactions: hypersensitivity reactions, fever; very rarely – Quincke’s edema. Dermatological reactions: itching, skin hyperemia, urticaria. Local reactions: rarely – tingling and redness at the injection site. Storage conditions The drug should be stored in a place protected from light, out of the reach of children, at a temperature of 15° to 25°C. Buy Thiotriazoline solution for intravenous and intramuscular injection 25mg/ml in ampoules 4ml №5×2 and intramuscular injections 25mg/ml in ampoules 4ml No. 5×2